Petrackova Anna, Smrzova Andrea, Gajdos Petr, Schubertova Marketa, Schneiderova Petra, Kromer Pavel, Snasel Vaclav, Skacelova Martina, Mrazek Frantisek, Zadrazil Josef, Horak Pavel, Kriegova Eva
Department of Immunology, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 3, 775 15 Olomouc, Czech Republic.
Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, University Hospital, Palacky University, Olomouc, Czech Republic.
Clin Proteomics. 2017 Oct 3;14:32. doi: 10.1186/s12014-017-9167-8. eCollection 2017.
Systemic lupus erythematosus (SLE) is a remarkably heterogeneous autoimmune disease. Despite tremendous efforts, our knowledge of serum protein patterns in severe SLE phenotypes is still limited. We investigated the serum protein pattern of SLE, with special emphasis on irreversible organ damage and active lupus nephritis (LN) as assessed by renal Systemic Lupus Erythematosus Disease Activity Index.
We used proximity extension immunoassay (PEA, Proseek Multiplex, Olink) to assess the serum levels of ninety-two inflammation-related proteins in Czech patients with SLE (n = 75) and age-matched healthy control subjects (n = 23). Subgroup analysis was carried out on the basis of organ damage (with/without, 42/33) and biopsy-proven LN (with/without, 27/48; active LN, n = 13; inactive LN, n = 14).
Of thirty deregulated proteins between SLE and the healthy controls ( < 0.05), the top upregulated proteins in SLE were sirtuin 2, interleukin 18 (IL18), and caspase 8 ( < 0.0006). Of these, sirtuin 2 and caspase 8 had not yet been reported with SLE. Elevated levels of IL8, CCL2/MCP1, CCL11, and MMP10 ( < 0.05) were detected in patients with organ damage for which the serum levels of CCL11 and MMP10 were particularly informative in organ damage prediction. Comparing patients based on LN, elevated levels of CSF1, sIL15RA, sCD40, sCX3CL1, caspase 8, sIL18R1, bNGF, and GDNF ( < 0.05) were detected in active LN. Except GDNF, all LN-associated markers showed usefulness in prediction of active renal disease.
This highly sensitive PEA analysis identified the serum pattern of SLE, organ damage, and active LN, with many novel candidate proteins detected. Their exact role and suitability as biomarkers in SLE deserve further investigation.
系统性红斑狼疮(SLE)是一种异质性显著的自身免疫性疾病。尽管付出了巨大努力,但我们对严重SLE表型的血清蛋白模式的了解仍然有限。我们研究了SLE的血清蛋白模式,特别关注通过肾脏系统性红斑狼疮疾病活动指数评估的不可逆器官损伤和活动性狼疮性肾炎(LN)。
我们使用邻位延伸免疫分析(PEA,Proseek Multiplex,Olink)来评估92种炎症相关蛋白在捷克SLE患者(n = 75)和年龄匹配的健康对照者(n = 23)中的血清水平。基于器官损伤(有/无,42/33)和活检证实的LN(有/无,27/48;活动性LN,n = 13;非活动性LN,n = 14)进行亚组分析。
在SLE与健康对照之间失调的30种蛋白中(P < 0.05),SLE中上调最明显的蛋白是沉默调节蛋白2、白细胞介素18(IL18)和半胱天冬酶8(P < 0.0006)。其中,沉默调节蛋白2和半胱天冬酶8尚未见与SLE相关的报道。在有器官损伤的患者中检测到IL8、CCL2/MCP1、CCL11和MMP10水平升高(P < 0.05),其中CCL11和MMP10的血清水平在器官损伤预测中具有特别的参考价值。基于LN比较患者,在活动性LN中检测到CSF1、sIL15RA、sCD40、sCX3CL1、半胱天冬酶8、sIL18R1、bNGF和GDNF水平升高(P < 0.05)。除GDNF外,所有与LN相关的标志物在预测活动性肾脏疾病方面均显示出作用。
这种高灵敏度的PEA分析确定了SLE、器官损伤和活动性LN的血清模式,检测到许多新的候选蛋白。它们在SLE中的确切作用以及作为生物标志物的适用性值得进一步研究。